Beranda › Karsinoma Sel Skuamosa › New York
Uji klinis Karsinoma Sel Skuamosa di New York
15 studi untuk Karsinoma Sel Skuamosa mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
- Richmond University Medical Center, Staten Island
- Montefiore Medical Center, The Bronx
Menerima pesertaFase 3
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04892173Intratumoral N17350 in Advanced Solid Tumors
- Roswell Park Comprehensive Cancer Center, Buffalo
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07339176A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06561685A Study of IDP-001 in Advanced or Metastatic Solid Tumors
- Roswell Park Cancer Institute, Buffalo
- START New York Long Island, Lake Success
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07602842Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- Wilmot Cancer Institute at the University of Rochester Medical Center in New Yor, Rochester
Menerima pesertaFase 2
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT04915183Two-photon Fluorescence Microscopy of Dermatologic Biopsies
- Rochester Dermatologic Surgery, Victor
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07773688Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies
- Rochester Dermatologic Surgery, Victor
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07682831A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT05859074Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology
- Memorial Sloan Kettering West Harrison (consent only), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- Memorial Sloan Kettering Nassau (consent only), Uniondale
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT02507141Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
- Bassett Healthcare, Cooperstown
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT06615635Raman Spectroscopy and Skin Cancer
- Stony Brook Hospital, Stony Brook
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Mei 2026 · NCT06384924A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Northwell Health Cancer Institute, Lake Success
- Manhattan Eye, Ear & Throat Hospital, New York
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT06064877Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
- NYU College of Dentistry, New York
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Nov 2025 · NCT07095608Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
- Bruce Robinson, MD, New York
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2025 · NCT07010692Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Memorial Sloan Kettering, New York
- Columbia University Herbert Irving Comprehensive Cancer Center, New York
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Agu 2025 · NCT04429542Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.